AI Article Synopsis

  • Improvements in diagnostic imaging have led to an increase in the diagnosis of intraductal papillary-mucinous tumors (IPMTs), which can range from benign hyperplasia to invasive carcinoma.
  • IPMTs are believed to develop through a progression from hyperplasia to carcinoma and exhibit genetic and histological diversity, but most have a favorable prognosis despite some progressing to aggressive pancreatic cancer.
  • Although both IPMTs and conventional pancreatic cancer start in the ductal epithelium, they are considered distinct due to differences in origin, development, genetic changes, and overall prognosis, with future studies focusing on their molecular similarities and differences.

Article Abstract

Many intraductal papillary-mucinous tumors (IPMTs) have been diagnosed with improvements in diagnostic imaging techniques. The histology of IPMT is various, including hyperplasia to invasive carcinoma. IPMTs are thought to occur multicentrically through the hyperplasia-adenoma-carcinoma sequence. IPMTs are characterized by genetic heterogeneity associated with histologic heterogeneity that may be due to slow growth and favorable prognosis. However, some IPMTs progress to invasive pancreatic cancer through malignant transformation with aggressive clonal progression. Thus some conventional pancreatic cancers may be derived from IPMTs. Although IPMTs and conventional pancreatic cancer initially occur in the ductal epithelium, they are thought to be totally different entities in terms of large or peripheral pancreatic duct origin, developmental style, genetic alterations, and prognosis. In future, differences and/or similarities will be discussed on the basis of molecular analyses of the carcinogensis of both tumors.

Download full-text PDF

Source

Publication Analysis

Top Keywords

intraductal papillary-mucinous
8
pancreatic cancer
8
conventional pancreatic
8
ipmts
6
[pathology intraductal
4
papillary-mucinous tumor
4
tumor pancreas]
4
pancreas] intraductal
4
papillary-mucinous tumors
4
tumors ipmts
4

Similar Publications

Endoscopic ultrasound (EUS) effectively diagnoses malignant and pre-malignant gastrointestinal lesions. In the past few years, artificial intelligence (AI) has shown promising results in enhancing EUS sensitivity and accuracy, particularly for subepithelial lesions (SELs) like gastrointestinal stromal tumors (GISTs). Furthermore, AI models have shown high accuracy in predicting malignancy in gastric GISTs and distinguishing between benign and malignant intraductal papillary mucinous neoplasms (IPMNs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!